Development of an early or core value dossier with MTRC

Every innovative technology has the challenge to communicate its value to different stakeholders. Why this health care problem is important (mortality, morbidity, impact on the quality of life, cost-of-illness)? What are the current treatment options and what are their limitations? What is the size of the population with high unmet needs? What is the proposed novel solution? Is it safe and effective? What are the economic consequences to the hospital and health care system? What are the organizational requirements for the introduction of a novel method?

Historically, these questions were answered by separate publications in peer-reviewed journals and marketing materials. However, they are typically not comprehensive enough, lack important information, and are too unstructured to support discussion with clinicians, reimbursement authorities, and payers.

The modern answer to the challenge of summarizing and presenting the value of the technology is the value dossier. A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The document is also used as a source of information for any reimbursement-related activities: from supporting local business cases to application to the national HTA.

There are two formats of the value dossier: early dossier - a relatively short (15-20 pages) document, based on a systematic but limited search with a focus on the key messages and data; core value dossier is a more comprehensive document (typically about 60-100 pages plus supplements) that covers a larger number of topics.

MTRC can provide support with the development of both early and core value dossiers. Typically, a dossier is developed either from a global or European perspective.

Learn more about our approach here.